About Reactive Biosciences
Reactive Biosciences is a Healthcare company based in Durham (United States) founded in 2021. Boron-based medicines are developed for diseases using computational methods. Reactive Biosciences has raised $23.5 million across 2 funding rounds. Its chief executive, as recorded, is Julie Grant. Reactive Biosciences offers products and services including Reactor Platform. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Drug Discovery. Its legal entity is REACTIVE BIOSCIENCES INC. Its competitors include NTxBio, Nimble Therapeutics and Applied BioMath; 3 of its 3 listed competitors have raised funding.
Company details
Reactive Biosciences was founded in 2021 and is based in Durham, United States. Boron-based drug discovery platforms are utilized by the company to target undruggable diseases through computational approaches. Medicines for various conditions are developed, focusing on innovative therapeutic solutions in the biotechnology sector. Operations emphasize the advancement of novel treatments from discovery to potential clinical stages.
- Headquarters Durham, United States
- SectorsHealthcare
- Email••••••••
- Website reactivebio.com
- Social LinkedIn
- Legal Name Reactive Biosciences Inc.
- Total Equity Funding$23.5M (USD)
in 2 rounds
- Latest Funding Round$4M (USD), Debt – Conventional
Jun 2023
Products & Services of Reactive Biosciences
Reactive Biosciences offers a comprehensive portfolio of products and services, including Reactor Platform.
Platform for developing boron-based medicines targeting undruggable diseases.
Funding Insights of Reactive Biosciences
Reactive Biosciences has successfully raised a total of $23.5M across 2 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $4 million completed in June 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $23.5M
- Total Rounds 2
- Last Round Debt – Conventional — $4M
- First Round $23.5M
(Sep 2022)
All 2 funding rounds of Reactive Biosciences with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2023 | $4M | Debt – Conventional | – | – | – |
| Sep 2022 | $23.5M | Series A | – | – | – |
People of Reactive Biosciences
3 people are tracked at Reactive Biosciences (2 in leadership, 1 in team).
| Name | Role | Group |
|---|---|---|
Julie Grant | CEO | Leadership |
Jake Plattner | SVP, Head of Chemistry | Leadership |
Yasheen Zhou | Computational Chemist | Team |
Complete people profiles for Reactive Biosciences
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Reactive Biosciences
3 dated milestones of Reactive Biosciences across 2 years, from founding to its latest funding, stage changes and deals.
- Founded Reactive Biosciences is founded.
- Funding First funding round of $23.5M.
- Funding Latest funding round, Debt – Conventional, of $4.0M.
Competitors of Reactive Biosciences
Reactive Biosciences has 3 listed competitors in our database, 3 of them funded. They include NTxBio, Nimble Therapeutics and Applied BioMath.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| ntxbio.com | 2016 | Santa Fe, United States | $74.76M | Provider of bio informatics platform to develops biologics and therapeutics | ||
| nimbletherapeutics.com | 2019 | Madison, United States | $10M | 24 | Combinatorial chemistry services for peptide-based drug discovery are provided. | |
| appliedbiomath.com | 2013 | Cambridge, United States | $2.32M | 61 | Systems biology and pharmacology modeling services to aid drug discovery and development |
Detailed competitors of Reactive Biosciences
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Reactive Biosciences (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Reactive Biosciences
Complete news archive for Reactive Biosciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Reactive Biosciences
Reactive Biosciences was founded in 2021 and raised its 1st funding round 1 year after it was founded.
Reactive Biosciences is headquartered in Durham, United States. It is registered at Durham, North Carolina, United States.
Julie Grant is the CEO of Reactive Biosciences, as recorded in our data.
Reactive Biosciences is a funded company, having raised a total of $23.5M across 2 funding rounds to date. The company's 1st funding round was a Series A of $23.5M, raised on Sep 2022.
Reactive Biosciences was founded in 2021 and is based in Durham, United States. Boron-based drug discovery platforms are utilized by the company to target undruggable diseases through computational approaches. Medicines for various conditions are developed, focusing on innovative therapeutic solutions in the biotechnology sector. Operations emphasize the advancement of novel treatments from discovery to potential clinical stages.
Reactive Biosciences's top competitors include NTxBio, Nimble Therapeutics and Applied BioMath.
Reactive Biosciences offers Reactor Platform.
Reactive Biosciences operates through Reactive Biosciences Inc..